Reporte zur Charge CUS 295

Symptomtext

Swimmers ear; Vertigo; brain fog; Shortness of breath trouble breathing; coughing; panic attacks; Anxiety; This a spontaneous report from a contactable consumer (patient). A 46-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Batch/Lot number: CUS 295) dose 1 via an unspecified route of administration, administered in left arm on 12Oct2021 at 12:00 hours as DOSE 1, SINGLE (at the age of 46-years-old) for COVID-19 immunization. The patient's medical history included bipolar disorder, hypertension, and cholesterol. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications within 2 weeks of vaccination included Lamotrigine (LAMICTAL); Atorvastatin calcium (LIPITOR); and Amlodipine besilate (NORVASC). The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 14Oct2021, the patient experienced swimmers' ear, vertigo, brain fog, shortness of breath trouble breathing, Anxiety, panic attacks, and coughing. The events were resulted in doctor/other health care professional office/clinic visit. Therapeutic measures were taken as a result of the events. Treatment received included ear drops and ibuprofen. The clinical outcome of the events was not recovered. Follow-up attempts are completed. No further information is expected.